Genmab | GEN - Market Capitalization


Genmab reported DKK120.17B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
Amgen USD 209.65B 14.21B Aug/2026
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bayer EUR 49.51B 10.82B Aug/2026
BioMarin Pharmaceutical USD 11.58B 712M Aug/2026
Demant DKK 46.01B 10.48B Dec/2025
Exelixis USD 16.2B 5.3B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Insmed USD 35.3B 1.82B Mar/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025